164 related articles for article (PubMed ID: 15485798)
21. [Strontium-89 for bone metastases from prostate cancer: an update].
Zhao WW; Xie P; Deng HF
Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
[TBL] [Abstract][Full Text] [Related]
22. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
[TBL] [Abstract][Full Text] [Related]
23. [The radiotherapeutic effect on bone metastases in relation to the frequency of metastases, sites of metastases and histology of the primary tumor].
Rieden K; Adolph J; Lellig U; zum Winkel K
Strahlenther Onkol; 1989 May; 165(5):380-5. PubMed ID: 2727892
[TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of IL-2 and TNF-alpha in patients with painful bone metastases: correlation with responses to 89SrCl2 therapy.
Fang N; Li Y; Xu YS; Ma D; Fu P; Gao HQ; Gao FT; Yang HS; Yang ZJ
J Nucl Med; 2006 Feb; 47(2):242-6. PubMed ID: 16455629
[TBL] [Abstract][Full Text] [Related]
25. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
[TBL] [Abstract][Full Text] [Related]
26. Decreased serum E-selectin concentration after 89Sr-chloride therapy for metastatic prostate cancer bone pain.
Papatheofanis FJ
J Nucl Med; 2000 Jun; 41(6):1021-4. PubMed ID: 10855628
[TBL] [Abstract][Full Text] [Related]
27. 89-Sr for the treatment of incurable pain in patient with neoplastic osseous infiltrations.
Schmidt CG; Firusian N
Int J Clin Pharmacol; 1974 Apr; 7(3):199-205. PubMed ID: 4855457
[No Abstract] [Full Text] [Related]
28. Treating symptomatic osseous metastases from prostate cancer.
Soffen EM; Greenberg AS; Baumann JC
N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
[No Abstract] [Full Text] [Related]
29. [Combined treatment for pain from bone metastases in patients with prostate cancer].
Ren X; Ying J; Yao D; Ye C; Jiang Y
Zhonghua Nan Ke Xue; 2004 Mar; 10(3):188-90. PubMed ID: 15080063
[TBL] [Abstract][Full Text] [Related]
30. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
Tu SM; Kim J; Pagliaro LC; Vakar-Lopez F; Wong FC; Wen S; General R; Podoloff DA; Lin SH; Logothetis CJ
J Clin Oncol; 2005 Nov; 23(31):7904-10. PubMed ID: 16258090
[TBL] [Abstract][Full Text] [Related]
31. [Use of strontium-89 in the analgesic treatment of bone metastases].
Hayek D; Ritschard J; Zwahlen A; Courvoisier B; Donath A
Schweiz Med Wochenschr; 1980 Aug; 110(31-32):1154-9. PubMed ID: 7444409
[TBL] [Abstract][Full Text] [Related]
32. [89Sr Therapy for pain relief in patients with bone metastases].
Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
[TBL] [Abstract][Full Text] [Related]
33. Radionuclide-targeted therapy for the management of metastatic bone pain.
Ackery D; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
[TBL] [Abstract][Full Text] [Related]
34. [The evaluation of the effectiveness of half-body irradiation as palliative treatment in patients with multiple bone metastases].
Miszczyk L; Sasiadek W
Przegl Lek; 2001; 58(5):431-4. PubMed ID: 11603177
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
[TBL] [Abstract][Full Text] [Related]
36. [Effect of Guliu capsule combined with 89Sr therapy on metastatic bone tumor].
Su XC; Wang YL; Yang XY; Liu CL; Yan BC; Kong JX; Song XL; Liang K
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1164-5, 1177. PubMed ID: 16174589
[TBL] [Abstract][Full Text] [Related]
37. 89Strontium in the management of painful sceletal metastases.
Kälkner KM; Westlin JE; Strang P
Anticancer Res; 2000; 20(2B):1109-14. PubMed ID: 10810404
[TBL] [Abstract][Full Text] [Related]
38. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
[TBL] [Abstract][Full Text] [Related]
39. The role of strontium-89 systemic radiotherapy in the management of osseous metastases from prostate cancer.
Soffen EM; Greenberg A; Baumann J; Corn BW
Tech Urol; 1997; 3(2):76-80. PubMed ID: 9297766
[TBL] [Abstract][Full Text] [Related]
40. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Storto G; Klain M; Paone G; Liuzzi R; Molino L; Marinelli A; Soricelli A; Pace L; Salvatore M
Bone; 2006 Jul; 39(1):35-41. PubMed ID: 16434248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
